Lapas
| Almost 200 Signatories Call To Dismantle Parallel Authorized Programs | Pēdējo reizi labota 2 nedēļas atpakaļ |
| GlaxoSmithKline Under Investigation For Allegedly Bribing Docs In China | Pēdējo reizi labota 2 nedēļas atpakaļ |
| Almost 200 Signatories Call To Dismantle Parallel Authorized Programs | Pēdējo reizi labota 2 nedēļas atpakaļ |
| GlaxoSmithKline Under Investigation For Allegedly Bribing Docs In China | Pēdējo reizi labota 2 nedēļas atpakaļ |